Search
- Page Path
- HOME > Search
Original Articles
- Antiviral Activity of Itraconazole against Echovirus 30 Infection
In Vitro - Jae-Sug Lee, Hwa-Jung Choi, Jae-Hyoung Song, Hyun-Jeong Ko, Kyungah Yoon, Jeong-Min Seong
- Osong Public Health Res Perspect. 2017;8(5):318-324. Published online October 31, 2017
- DOI: https://doi.org/10.24171/j.phrp.2017.8.5.05
- 4,348 View
- 28 Download
- 7 Crossref
-
Abstract
PDF Objectives Echovirus 30 is a major cause of meningitis in children and adults. The aim of this study was to investigate whether the antifungal drug itraconazole could exhibit antiviral activity against echovirus 30.
Methods The cytopathic effect and viral RNA levels were assessed in RD cells as indicators of viral replication. The effects of itraconazole were compared to those of two known antiviral drugs, rupintrivir and pleconaril. The time course and time-of-addition assays were used to approximate the time at which itraconazole exerts its activity in the viral cycle.
Results Itraconazole and rupintrivir demonstrated the greatest potency against echovirus 30, demonstrating concentration-dependent activity, whereas pleconaril showed no antiviral activity. Itraconazole did not directly inactivate echovirus 30 particles or impede viral uptake into RD cells, but did affect the initial stages of echovirus 30 infection through interference with viral replication.
Conclusion Itraconazole can be considered a lead candidate for the development of antiviral drugs against echovirus 30 that may be used during the early stages of echovirus 30 replication.
-
Citations
Citations to this article as recorded by
- Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
Chiara Tammaro, Michela Guida, Federico Appetecchia, Mariangela Biava, Sara Consalvi, Giovanna Poce
Pharmaceuticals.2023; 16(2): 203. CrossRef - Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
Leena Abdulaziz, Esraa Elhadi, Ejlal A Abdallah, Fadlalbaseer A Alnoor, Bashir A Yousef
Journal of Experimental Pharmacology.2022; Volume 14: 97. CrossRef - Identification of novel Ebola virus inhibitors using biologically contained virus
Bert Vanmechelen, Joren Stroobants, Winston Chiu, Joost Schepers, Arnaud Marchand, Patrick Chaltin, Kurt Vermeire, Piet Maes
Antiviral Research.2022; 200: 105294. CrossRef - The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication
Lucca Policastro, Isabela Dolci, Andre Godoy, José Silva Júnior, Uriel Ruiz, Igor Santos, Ana Jardim, Kirandeep Samby, Jeremy Burrows, Timothy Wells, Laura Gil, Glaucius Oliva, Rafaela Fernandes
Viruses.2022; 14(7): 1351. CrossRef - Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle
Eric Rhoden, Terry Fei Fan Ng, Ray Campagnoli, W. Allan Nix, Jennifer Konopka-Anstadt, Rangaraj Selvarangan, Laurence Briesach, M. Steven Oberste, William C. Weldon
Antimicrobial Agents and Chemotherapy.2020;[Epub] CrossRef - Potential antiviral properties of antifungal drugs
FalahH.O Al-Khikani, HudaA.S Almosawey, YounusJ Abdullah, AtyafA Al-Asadi, RaghdahM Hameed, NoorF Hasan, MohanadK.M Al-Ibraheemi
Journal of the Egyptian Women's Dermatologic Socie.2020; 17(3): 185. CrossRef - Repurposing approach identifies new treatment options for invasive fungal disease
Isis Regina Grenier Capoci, Daniella Renata Faria, Karina Mayumi Sakita, Franciele Abigail Vilugron Rodrigues-Vendramini, Patricia de Souza Bonfim-Mendonça, Tania Cristina Alexandrino Becker, Érika Seki Kioshima, Terezinha Inez Estivalet Svidzinski, Berna
Bioorganic Chemistry.2019; 84: 87. CrossRef
- Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
- Complete Sequence Analysis and Antiviral Screening of Medicinal Plants for Human Coxsackievirus A16 Isolated in Korea
- Jae-Hyoung Song, Kwisung Park, Aeri Shim, Bo-Eun Kwon, Jae-Hee Ahn, Young Jin Choi, Jae Kyung Kim, Sang-Gu Yeo, Kyungah Yoon, Hyun-Jeong Ko
- Osong Public Health Res Perspect. 2015;6(1):52-58. Published online February 28, 2015
- DOI: https://doi.org/10.1016/j.phrp.2014.12.004
- 2,750 View
- 18 Download
- 15 Crossref
-
Abstract
PDF
- Objectives
Coxsackievirus A group 16 strain (CVA16) is one of the predominant causative agents of hand, foot, and mouth disease (HFMD).
Methods
Using a specimen from a male patient with HFMD, we isolated and performed sequencing of the Korean CVA16 strain and compared it with a G10 reference strain. Also, we were investigated the effects of medicinal plant extract on the cytopathic effects (CPE) by CPE reduction assay against Korean CVA16.
Results
Phylogenetic analysis showed that the Korean CVA16 isolate belonged to cluster B-1 and was closely related to the strain PM-15765-00 isolated in Malaysia in 2000. The Korean CVA16 isolate showed 73.2% nucleotide identity to the G10 prototype strain and 98.7% nucleotide identity to PM-15765-00. Next, we assessed whether the Korean CVA16 isolate could be used for in vitro screening of antiviral agents to treat HFMD infection. Vero cells infected with the Korean CVA16 isolate showed a cytopathic effect 2 days after the infection, and the treatment of cells with Cornus officinalis, Acer triflorum, Pulsatilla koreana, and Clematis heracleifolia var. davidiana Hemsl extracts exhibited strong antiviral activity against CVA16.
Conclusion
Collectively, our work provides potential candidates for the development of vaccine and novel drugs to treat the CVA16 strain isolated from a Korean patient. -
Citations
Citations to this article as recorded by- Recent advances in anti-coxsackievirus A16 viral drug research
Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Future Medicinal Chemistry.2023; 15(1): 97. CrossRef - A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy
Nur Fadlin Saifulazmi, Emelda Rosseleena Rohani, Sarahani Harun, Hamidun Bunawan, Hamizah Shahirah Hamezah, Nor Azlan Nor Muhammad, Kamalrul Azlan Azizan, Qamar Uddin Ahmed, Sharida Fakurazi, Ahmed Mediani, Murni Nazira Sarian
Life.2022; 12(8): 1287. CrossRef - Medicinal plants: Treasure for antiviral drug discovery
Sofi Imtiyaz Ali, Wajid Mohammad Sheikh, Muzafar Ahmad Rather, Venugopalan Venkatesalu, Showkeen Muzamil Bashir, Showkat Ul Nabi
Phytotherapy Research.2021; 35(7): 3447. CrossRef - Seasonal Distribution and Meteorological Factors Associated with Hand, Foot, and Mouth Disease among Children in Xi’an, Northwestern China
Tianci Guo, Jifeng Liu, Junjiang Chen, Yao Bai, Yong Long, Baozhong Chen, Shuxuan Song, Zhongjun Shao, Kun Liu
The American Journal of Tropical Medicine and Hygi.2020; 102(6): 1253. CrossRef - Short-term effects of meteorological factors and air pollution on childhood hand-foot-mouth disease in Guilin, China
Guoqi Yu, Yonghong Li, Jiansheng Cai, Dongmei Yu, Jiexia Tang, Wenwen Zhai, Yi Wei, Shiyi Chen, Quanhui Chen, Jian Qin
Science of The Total Environment.2019; 646: 460. CrossRef - The effect of temperature on childhood hand, foot and mouth disease in Guangdong Province, China, 2010–2013: a multicity study
Zece Xu, Wenqi Hu, Kedi Jiao, Ci Ren, Baofa Jiang, Wei Ma
BMC Infectious Diseases.2019;[Epub] CrossRef - Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017
Tianjiao Ji, Taoli Han, Xiaojuan Tan, Shuangli Zhu, Dongmei Yan, Qian Yang, Yang Song, Aili Cui, Yan Zhang, Naiying Mao, Songtao Xu, Zhen Zhu, Dandan Niu, Yong Zhang, Wenbo Xu
Biosafety and Health.2019; 1(1): 32. CrossRef - A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
Ruixiao Du, Qunying Mao, Yalin Hu, Shuhui Lang, Shiyang Sun, Kelei Li, Fan Gao, Lianlian Bian, Ce Yang, Bopei Cui, Longfa Xu, Tong Cheng, Zhenglun Liang
Human Vaccines & Immunotherapeutics.2019; 15(10): 2343. CrossRef - Corni Fructus: a review of chemical constituents and pharmacological activities
Yu Dong, Zhe-Ling Feng, Hu-Biao Chen, Fu-Sheng Wang, Jia-Hong Lu
Chinese Medicine.2018;[Epub] CrossRef - Inhibition of Murine Norovirus and Feline Calicivirus by Edible Herbal Extracts
Dong Joo Seo, Changsun Choi
Food and Environmental Virology.2017; 9(1): 35. CrossRef - Antiviral activity of herbal extracts against the hepatitis A virus
Dong Joo Seo, Minhwa Lee, Su Been Jeon, Hyunkyung Park, Suntak Jeong, Bog-Hieu Lee, Changsun Choi
Food Control.2017; 72: 9. CrossRef - A novel Enterovirus 96 circulating in China causes hand, foot, and mouth disease
Yi Xu, Yisuo Sun, Jinmin Ma, Shuru Zhou, Wei Fang, Jiawei Ye, Limei Tan, Jingkai Ji, Dan Luo, Liqiang Li, Jiandong Li, Chunxiao Fang, Na Pei, Shuo Shi, Xin Liu, Hui Jiang, Sitang Gong, Xun Xu
Virus Genes.2017; 53(3): 352. CrossRef - Characterization of VP1 sequence of Coxsackievirus A16 isolates by Bayesian evolutionary method
Guolian Zhao, Xun Zhang, Changmin Wang, Guoqing Wang, Fan Li
Virology Journal.2016;[Epub] CrossRef - Traditional uses, phytochemistry, and pharmacology of the genus Acer (maple): A review
Wu Bi, Ying Gao, Jie Shen, Chunnian He, Haibo Liu, Yong Peng, Chunhong Zhang, Peigen Xiao
Journal of Ethnopharmacology.2016; 189: 31. CrossRef - Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland China
Zhi-Chao Zhuang, Zeng-Qiang Kou, Yong-Juan Bai, Xiang Cong, Li-Hong Wang, Chun Li, Li Zhao, Xue-Jie Yu, Zhi-Yu Wang, Hong-Ling Wen
Viruses.2015; 7(12): 6400. CrossRef
- Recent advances in anti-coxsackievirus A16 viral drug research
First
Prev
